Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: Implications for CXCL12/CXCR4 axis in lymphoma generation

Erich Piovan, Valeria Tosello, Stefano Indraccolo, Anna Cabrelle, Ilenia Baesso, Livio Trentin, Rita Zamarchi, Hirokazu Tamamura, Nobutaka Fujii, Gianpietro Semenzato, Luigi Chieco-Bianchi, Alberto Amadori

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The mechanisms by which intraperitoneal injection of peripheral blood mononuclear cells (PBMCs) from Epstein-Barr virus (EBV)-seropositive donors into severe combined immunodeficient (SCID) mice gives rise to lymphomas (hu/SCID tumors) are far from clear. This study addressed whether chemokine receptors and their ligands could be implicated in this experimental model. CXCR4 was found to be highly expressed in hu/SCID tumors; surface expression of CXCR4 was prevalently limited to a tumor cell subset poorly expressing CD23, whereas the CXCR4 ligand, CXCL12, was predominantly expressed by the tumor subpopulation expressing CD23. In vitro inhibition of this autocrine/paracrine CXCL12/ CXCR4 axis significantly inhibited lymphoma proliferation and survival. Furthermore, CXCL12 was expressed in cells recovered from the mouse peritoneal cavity early after PBMC transfer as well as by EBV-transformed B cells but not by resting or activated B lymphocytes; also, lymphoma development was associated with a dramatic increase in the levels of murine CXCL12 present in the peritoneal cavity. Finally, antagonizing the CXCL12/ CXCR4 axis in vivo strongly counteracted lymphoma development. These studies demonstrate that CXCL12 expression may be associated with EBV infection and suggest that the CXCR4/CXCL12 axis may participate in the EBV-associated lymphomagenesis process in immunodeficient hosts.

Original languageEnglish
Pages (from-to)931-939
Number of pages9
JournalBlood
Volume105
Issue number3
DOIs
Publication statusPublished - Feb 1 2005

Fingerprint

SCID Mice
Chemokine Receptors
Human Herpesvirus 4
Viruses
Tumors
Lymphoma
Peritoneal Cavity
Blood Cells
Neoplasms
Blood
B-Lymphocytes
Cells
Ligands
Epstein-Barr Virus Infections
Lymphocytes
Intraperitoneal Injections
Theoretical Models

ASJC Scopus subject areas

  • Hematology

Cite this

Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice : Implications for CXCL12/CXCR4 axis in lymphoma generation. / Piovan, Erich; Tosello, Valeria; Indraccolo, Stefano; Cabrelle, Anna; Baesso, Ilenia; Trentin, Livio; Zamarchi, Rita; Tamamura, Hirokazu; Fujii, Nobutaka; Semenzato, Gianpietro; Chieco-Bianchi, Luigi; Amadori, Alberto.

In: Blood, Vol. 105, No. 3, 01.02.2005, p. 931-939.

Research output: Contribution to journalArticle

Piovan, Erich ; Tosello, Valeria ; Indraccolo, Stefano ; Cabrelle, Anna ; Baesso, Ilenia ; Trentin, Livio ; Zamarchi, Rita ; Tamamura, Hirokazu ; Fujii, Nobutaka ; Semenzato, Gianpietro ; Chieco-Bianchi, Luigi ; Amadori, Alberto. / Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice : Implications for CXCL12/CXCR4 axis in lymphoma generation. In: Blood. 2005 ; Vol. 105, No. 3. pp. 931-939.
@article{311846c2d6254bdba316103880fa04d7,
title = "Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: Implications for CXCL12/CXCR4 axis in lymphoma generation",
abstract = "The mechanisms by which intraperitoneal injection of peripheral blood mononuclear cells (PBMCs) from Epstein-Barr virus (EBV)-seropositive donors into severe combined immunodeficient (SCID) mice gives rise to lymphomas (hu/SCID tumors) are far from clear. This study addressed whether chemokine receptors and their ligands could be implicated in this experimental model. CXCR4 was found to be highly expressed in hu/SCID tumors; surface expression of CXCR4 was prevalently limited to a tumor cell subset poorly expressing CD23, whereas the CXCR4 ligand, CXCL12, was predominantly expressed by the tumor subpopulation expressing CD23. In vitro inhibition of this autocrine/paracrine CXCL12/ CXCR4 axis significantly inhibited lymphoma proliferation and survival. Furthermore, CXCL12 was expressed in cells recovered from the mouse peritoneal cavity early after PBMC transfer as well as by EBV-transformed B cells but not by resting or activated B lymphocytes; also, lymphoma development was associated with a dramatic increase in the levels of murine CXCL12 present in the peritoneal cavity. Finally, antagonizing the CXCL12/ CXCR4 axis in vivo strongly counteracted lymphoma development. These studies demonstrate that CXCL12 expression may be associated with EBV infection and suggest that the CXCR4/CXCL12 axis may participate in the EBV-associated lymphomagenesis process in immunodeficient hosts.",
author = "Erich Piovan and Valeria Tosello and Stefano Indraccolo and Anna Cabrelle and Ilenia Baesso and Livio Trentin and Rita Zamarchi and Hirokazu Tamamura and Nobutaka Fujii and Gianpietro Semenzato and Luigi Chieco-Bianchi and Alberto Amadori",
year = "2005",
month = "2",
day = "1",
doi = "10.1182/blood-2004-03-0799",
language = "English",
volume = "105",
pages = "931--939",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice

T2 - Implications for CXCL12/CXCR4 axis in lymphoma generation

AU - Piovan, Erich

AU - Tosello, Valeria

AU - Indraccolo, Stefano

AU - Cabrelle, Anna

AU - Baesso, Ilenia

AU - Trentin, Livio

AU - Zamarchi, Rita

AU - Tamamura, Hirokazu

AU - Fujii, Nobutaka

AU - Semenzato, Gianpietro

AU - Chieco-Bianchi, Luigi

AU - Amadori, Alberto

PY - 2005/2/1

Y1 - 2005/2/1

N2 - The mechanisms by which intraperitoneal injection of peripheral blood mononuclear cells (PBMCs) from Epstein-Barr virus (EBV)-seropositive donors into severe combined immunodeficient (SCID) mice gives rise to lymphomas (hu/SCID tumors) are far from clear. This study addressed whether chemokine receptors and their ligands could be implicated in this experimental model. CXCR4 was found to be highly expressed in hu/SCID tumors; surface expression of CXCR4 was prevalently limited to a tumor cell subset poorly expressing CD23, whereas the CXCR4 ligand, CXCL12, was predominantly expressed by the tumor subpopulation expressing CD23. In vitro inhibition of this autocrine/paracrine CXCL12/ CXCR4 axis significantly inhibited lymphoma proliferation and survival. Furthermore, CXCL12 was expressed in cells recovered from the mouse peritoneal cavity early after PBMC transfer as well as by EBV-transformed B cells but not by resting or activated B lymphocytes; also, lymphoma development was associated with a dramatic increase in the levels of murine CXCL12 present in the peritoneal cavity. Finally, antagonizing the CXCL12/ CXCR4 axis in vivo strongly counteracted lymphoma development. These studies demonstrate that CXCL12 expression may be associated with EBV infection and suggest that the CXCR4/CXCL12 axis may participate in the EBV-associated lymphomagenesis process in immunodeficient hosts.

AB - The mechanisms by which intraperitoneal injection of peripheral blood mononuclear cells (PBMCs) from Epstein-Barr virus (EBV)-seropositive donors into severe combined immunodeficient (SCID) mice gives rise to lymphomas (hu/SCID tumors) are far from clear. This study addressed whether chemokine receptors and their ligands could be implicated in this experimental model. CXCR4 was found to be highly expressed in hu/SCID tumors; surface expression of CXCR4 was prevalently limited to a tumor cell subset poorly expressing CD23, whereas the CXCR4 ligand, CXCL12, was predominantly expressed by the tumor subpopulation expressing CD23. In vitro inhibition of this autocrine/paracrine CXCL12/ CXCR4 axis significantly inhibited lymphoma proliferation and survival. Furthermore, CXCL12 was expressed in cells recovered from the mouse peritoneal cavity early after PBMC transfer as well as by EBV-transformed B cells but not by resting or activated B lymphocytes; also, lymphoma development was associated with a dramatic increase in the levels of murine CXCL12 present in the peritoneal cavity. Finally, antagonizing the CXCL12/ CXCR4 axis in vivo strongly counteracted lymphoma development. These studies demonstrate that CXCL12 expression may be associated with EBV infection and suggest that the CXCR4/CXCL12 axis may participate in the EBV-associated lymphomagenesis process in immunodeficient hosts.

UR - http://www.scopus.com/inward/record.url?scp=19944433306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944433306&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-03-0799

DO - 10.1182/blood-2004-03-0799

M3 - Article

C2 - 15454484

AN - SCOPUS:19944433306

VL - 105

SP - 931

EP - 939

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -